Article
Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype.
American journal of respiratory and critical care medicine - 1 Oct 2000
Fowler S J, Dempsey O J, Sims E J, Lipworth B J
Abstract excerpt
Bronchial hyperresponsiveness (BHR) is a key feature of asthma and may be measured by direct methacholine challenge or indirect adenosine monophosphate (AMP) challenge. We performed a retrospective analysis of our database (n = 487) of patients with asthma with the aim first, to compare methacholine and AMP challenge as screening tools, and second, to identify any relationships between BHR and disease severity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
